Regeneron Pharmaceuticals
REGN
#215
Rank
A$129.38 B
Marketcap
$1,177
Share price
-3.00%
Change (1 day)
-3.58%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total debt

Total debt on the balance sheet as of September 2024 : A$4.19 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total debt is A$4.19 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Regeneron Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$3.96 B-0.06%
2022-12-31A$3.96 B6.6%
2021-12-31A$3.72 B6.22%
2020-12-31A$3.50 B243.82%
2019-12-31A$1.01 B1.39%
2018-12-31A$1.00 B11.61%
2017-12-31A$0.90 B35.01%
2016-12-31A$0.66 B33.98%
2015-12-31A$0.49 B-10.92%
2014-12-31A$0.55 B-1.13%
2013-12-31A$0.56 B28.54%
2012-12-31A$0.44 B3.6%
2011-12-31A$0.42 B169.62%
2010-12-31A$0.15 B29.81%
2009-12-31A$0.12 B1581.21%
2008-12-31A$7.21 M-96.84%
2007-12-31A$0.22 B-9.83%
2006-12-31A$0.25 B-7.18%
2005-12-31A$0.27 B5.76%
2004-12-31A$0.25 B-10.15%
2003-12-31A$0.28 B-19.03%
2002-12-31A$0.35 B-9.61%
2001-12-31A$0.39 B8096.2%
2000-12-31A$4.79 M-23.15%
1999-12-31A$6.23 M-9.04%
1998-12-31A$6.85 M-20.2%
1997-12-31A$8.59 M-21.51%
1996-12-31A$10.95 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$93.69 B 2,133.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.01 B-51.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.31 B 145.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$55.45 B 1,222.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.88 B 1,089.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$39.49 B 841.59%๐Ÿ‡ซ๐Ÿ‡ท France